FOLH1 and neoplasm: These findings are consistent with the increasing evidence suggesting that in vivo tumor targeting is not only determined by the PSMA-binding motif in these molecules, but is also facilitated by properties such as charge, hydrophobicity, and overall molecular structure of the ligands 18, 19, 31.